AUSTIN, Texas, May 7, 2016 /PRNewswire/ -- The ART BMC bone marrow concentration systems are best-in-class devices for the point-of-care concentration of bone marrow aspirate (BMA). The systems recover the greatest percentage of nucleated and progenitor cells by allowing selection of the cell concentrate from user-defined portions of the centrifuged stack.
The new system by Celling Biosciences concentrates autologous bone marrow aspirate effectively and efficiently at the point-of-care in 15 minutes. Essential cell, growth factors and proteins are found within the stratified stack of the bone marrow concentrate. The dual capture system of the ART BMC Plus allows users to selectively deconstruct the stack in order to optimize the composition of the final preparation (e.g. BMC, fibrinogen, etc).
This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/the-art-bmc-system-by-celling-biosciences-is-revolutionizing-the-practice-of-cell-therapy-300264674.html
|SOURCE Celling Biosciences|
Copyright©2016 PR Newswire.
All rights reserved